Marijuana Stocks & Publicly Traded Cannabis Companies

Canadian marijuana stocks pare losses, could benefit long term from Sessions decision

Canadian marijuana stocks initially tumbled Thursday but then pared their losses after U.S. Attorney General Jeff Sessions abandoned an Obama-era policy that permitted the cannabis industry to operate in states across America.

Analysts said the surprise decision could end up being a “net positive” for Canadian firms with no U.S. operations – and funnel more investment money into local cannabis businesses

Read More

Canada’s CannaRoyalty makes headway into California’s cannabis market

CannaRoyalty said two California companies it is acquiring have received licenses to operate in the state’s new recreational cannabis market, positioning the Ontario-based business to capitalize on the largest legal cannabis market in the world. Alta Supply’s license, acquired Jan. 2, allows it to distribute CannaRoyalty’s own brands – plus products for over a dozen cannabis […]

Read More

Cronos increased financing deal to secure CA$40M for marijuana R&D

A Canadian medical marijuana producer announced a stock-purchase deal to raise 40 million Canadian dollars ($32 million) in capital, which it intends to apply to research and development.

After the deal closes later this month, Cronos will have raised more than CA$130 million since the beginning of 2017, including CA$40 million in debt.

Read More

Marijuana ETF begins trading on US exchange

Marijuana investors have a new fund to watch as the new year approaches. ETFMG Alternative Harvest ETF – a cannabis-focused exchange-traded fund – made its debut on NYSE Arca this week with 31 holdings. NYSE Arca investors trade both stocks and options. An ETF owns and tracks certain assets and, unlike a mutual fund, can be traded […]

Read More

Two companies form ‘Canada’s first’ retail-focused craft cannabis producer

Two British Columbia-based marijuana companies agreed to a merger, creating what they’re billing as Canada’s first retail-focused, craft cannabis producer. DOJA Cannabis, traded on the Canadian Securities Exchange, and Tokyo Smoke are joining forces to form Hiku Brands Company Ltd. Under the terms of the deal, DOJA will purchase all of the issued and outstanding […]

Read More

Canada’s largest pharmacy locks up more medical cannabis supply

Canada’s largest pharmacy chain signed up another major supplier of medical marijuana, further cementing what analysts called the “groundbreaking” entry of traditional pharmacies into the MMJ industry earlier this month. The latest deal has Shoppers Drug Mart entering an agreement to obtain an undisclosed amount of medical cannabis from MedReleaf Corp. MedReleaf, based in Markham […]

Read More

Cronos CEO Mike Gorenstein: ‘Reckoning’ is coming for Canada’s marijuana companies

Cronos Group isn’t the kind of company to promise the moon and deliver a pizza. That’s why the Toronto-based firm announced its intentions for a massive expansion after breaking ground on a 315,000-square-foot facility earlier this year. It’s all part of CEO Mike Gorenstein’s plan to be realistic with the company’s production targets. “This is […]

Read More

MassRoots facing eviction from Denver office

Cannabis-focused social media platform MassRoots could be evicted from its Denver offices unless the company pays nearly $40,000 in back rent. According to The Cannabist, the embattled publicly traded company owes $39,742 to its landlord and hasn’t paid its rent since August. An eviction notice dated Dec. 18 was posted on MassRoots’ office door, The Cannabist […]

Read More

Organigram plans to increase marijuana production via CA$73 million raise

The largest producer of medical marijuana on Canada’s East Coast said it signed three separate deals to secure roughly 73 million Canadian dollars ($57 million), with much of the funding going to boost its production capacity. Organigram said in a news release it sealed a stock-purchase deal to raise CA$57.5 million in capital. Eighty percent of […]

Read More

Global cannabis industry raises whopping $2.7 billion in 2017

Medical marijuana companies around the world have raised $2.7 billion so far this year to capitalize on explosive growth in the industry, an almost 300% increase from the same time last year. More than half that total, $1.6 billion, was raised in Canada via 189 transactions, the Financial Post reported. The data was compiled by […]

Read More

MassRoots board resigns; Dietrich reinstated as CEO

In the latest development in the MassRoots saga, three members of the board of directors have resigned, and former CEO Isaac Dietrich has been reinstated under the terms of a deal struck between the four of them.

“I am back at MassRoots,” an elated Dietrich told Marijuana Business Daily on Wednesday.

Read More

Aphria inks deal to secure CA$100 million for M&As, expansion

One of Canada’s largest medical marijuana producers announced a stock-purchase deal to raise 100 million Canadian dollars ($77.7 million) in capital, which it intends to apply to the construction of new production facilities globally and in Canada. To date in fiscal 2017, Aphria has raised CA$237 million, CFO Carl Merton told Marijuana Business Daily. This does not […]

Read More